Skip to main content

Advertisement

SpringerLink
Log in

Reduction of 5-azacitidine induced skin reactions in MDS patients with evening primrose oil

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Fenaux P, Mufti GJ, Hellstrom-Lindberg E et al (2009) Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study. Lancet Oncol 10:223–232

    Article  CAS  PubMed  Google Scholar 

  2. Lyons RM, Cosgriff TM, Modi SS et al (2009) Hematologic response to three alternative dosing schedules of azacitidine in patients with myelodysplastic syndromes. J Clin Oncol 27:1850–1856

    Article  CAS  PubMed  Google Scholar 

  3. Garcia-Manero G, Stoltz ML, Ward MR, Kantarjian H, Sharma S (2008) A pilot pharmacokinetic study of oral azacitidine. Leukemia 22:1680–1684

    Article  CAS  PubMed  Google Scholar 

  4. Muller-Thomas C, Schuster T, Peschel C, Gotze K (2009) A limited number of 5-azacitidine cycles can be effective treatment in MDS. Ann Hematol 88:213–219

    Article  PubMed  Google Scholar 

  5. Platzbecker U, Radke J, Kiani A et al (2009) 5-Azacitidine treatment for imminent relapse in patients with high-risk myelodysplastic syndromes or acute myeloid leukaemia after allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 43:S81

    Google Scholar 

  6. Senapati S, Banerjee S, Gangopadhyay DN (2008) Evening primrose oil is effective in atopic dermatitis: a randomized placebo-controlled trial. Indian J Dermatol Venereol Leprol 74:447–452

    Article  PubMed  Google Scholar 

  7. Yoon S, Lee J, Lee S (2002) The therapeutic effect of evening primrose oil in atopic dermatitis patients with dry scaly skin lesions is associated with the normalization of serum gamma-interferon levels. Skin Pharmacol Appl Skin Physiol 15:20–25

    CAS  PubMed  Google Scholar 

Download references

Acknowledgment

We thank the initial MDS patient (S.V.) from Dresden for his advice.

Author information

Authors and Affiliations

  1. Medizinische Klinik und Poliklinik I, Universitätsklinikum “Carl Gustav Carus” Dresden, 01307, Dresden, Germany

    Uwe Platzbecker & Gerhard Ehninger

  2. St. Johannes Hospital Duisburg, Duisburg, Germany

    Carlo Aul & Aristoteles Giagounidis

Authors
  1. Uwe Platzbecker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carlo Aul
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gerhard Ehninger
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Aristoteles Giagounidis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Uwe Platzbecker.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Platzbecker, U., Aul, C., Ehninger, G. et al. Reduction of 5-azacitidine induced skin reactions in MDS patients with evening primrose oil. Ann Hematol 89, 427–428 (2010). https://doi.org/10.1007/s00277-009-0824-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-009-0824-5

Keywords

Search

Navigation